Want to create an interactive transcript for this episode?
Podcast: BioCentury This Week
Episode: Ep. 216 - Anti-China Biotech Policy: Biosecure & Beyond
Description: Anti-China biotech bills are raising alarms at U.S. biotechs, with CEOs worried they could lose access to CDMOs WuXi AppTec and WuXi Biologics, and that legislation could imperil collaboration with Chinese companies more broadly. BIO has warned Congress the bills “would immediately and negatively” affect the U.S. biotech ecosystem. On this special edition of the BioCentury This Week podcast BioCentury Washington Editor Steve Usdin and colleagues discuss the pending legislation.Reach us by sending a text